Cancer Research Versailles No Abst  Advances in Breast Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Abaji, C.
Right arrow Articles by Belmaaza, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abaji, C.
Right arrow Articles by Belmaaza, A.
[Cancer Research 65, 4117-4125, May 15, 2005]
© 2005 American Association for Cancer Research


Molecular Biology, Pathobiology, and Genetics

BRCA2 Regulates Homologous Recombination in Response to DNA Damage: Implications for Genome Stability and Carcinogenesis

Christine Abaji1, Isabelle Cousineau2 and Abdellah Belmaaza3

Departments of 1 Biochemistry, 2 Molecular Biology Program, and 3 Medicine and Microbiology, Centre de recherche, Centre hospitalier de l'université de Montréal-Hôpital Notre-Dame, Institut du Cancer de Montréal, Université de Montréal, Montréal, Québec, Canada

Requests for reprints: Abdellah Belmaaza, Centre de Recherche du Centre hospitalier de l'université de Montréal-Hôpital Notre-Dame, Institut du cancer de Montréal, 1560, rue Sherbrooke est, Pavillon J.A. de Sève, Y-5634, Montréal, Québec, Canada H2L 4M1. Phone: 514-890-8000, ext. 28946; Fax: 514-412-7591; E-mail: belmaaza{at}magellan.umontreal.ca.

BRCA2 has been implicated in the maintenance of genome stability and RAD51-mediated homologous recombination repair of chromosomal double-strand breaks (DSBs), but its role in these processes is unclear. To gain more insight into its role in homologous recombination, we expressed wild-type BRCA2 in the well-characterized BRCA2-deficient human cell line CAPAN-1 containing, as homologous recombination substrates, either direct or inverted repeats of two inactive marker genes. Whereas direct repeats monitor a mixture of RAD51-dependent and RAD51-independent homologous recombination events, inverted repeats distinguish between these events by reporting RAD51-dependent homologous recombination, gene conversion, and crossover events only. At either repeats, BRCA2 decreases the rate and frequency of spontaneous homologous recombination, but following chromosomal DSBs, BRCA2 increases the frequency of homologous recombination. At direct repeats, BRCA2 suppresses both spontaneous gene conversion and deletions, which can arise either from crossover or RAD51-independent sister chromatid replication slippage (SCRS), but following chromosomal DSBs, BRCA2 highly promotes gene conversion with little effect on deletions. At inverted repeats, spontaneous or DSB-induced crossover events were scarce and BRCA2 does not suppress their formation. From these results, we conclude that (i) BRCA2 regulates RAD51 recombination in response to the type of DNA damage and (ii) BRCA2 suppresses SCRS, suggesting a role for BRCA2 in sister chromatids cohesion and/or alignment. Loss of such control in response to estrogen-induced DNA damage after BRCA2 inactivation may be a key initial event triggering genome instability and carcinogenesis.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
S.-l. Ding, J.-C. Yu, S.-T. Chen, G.-C. Hsu, S.-J. Kuo, Y. H. Lin, P.-E. Wu, and C.-Y. Shen
Genetic variants of BLM interact with RAD51 to increase breast cancer susceptibility
Carcinogenesis, January 1, 2009; 30(1): 43 - 49.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Chan, M. Koritzinsky, H. Zhao, R. Bindra, P. M. Glazer, S. Powell, A. Belmaaza, B. Wouters, and R. G. Bristow
Chronic Hypoxia Decreases Synthesis of Homologous Recombination Proteins to Offset Chemoresistance and Radioresistance
Cancer Res., January 15, 2008; 68(2): 605 - 614.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. Shen, Q. Lan, L. Zhang, S. Chanock, G. Li, R. Vermeulen, S. M. Rappaport, W. Guo, R. B. Hayes, M. Linet, et al.
Polymorphisms in genes involved in DNA double-strand break repair pathway and susceptibility to benzene-induced hematotoxicity
Carcinogenesis, October 1, 2006; 27(10): 2083 - 2089.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
I. Cousineau, C. Abaji, and A. Belmaaza
BRCA1 Regulates RAD51 Function in Response to DNA Damage and Suppresses Spontaneous Sister Chromatid Replication Slippage: Implications for Sister Chromatid Cohesion, Genome Stability, and Carcinogenesis
Cancer Res., December 15, 2005; 65(24): 11384 - 11391.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.